Your browser doesn't support javascript.
loading
Methodology to estimate natural- and vaccine-induced antibodies to SARS-CoV-2 in a large geographic region.
DeSantis, Stacia M; León-Novelo, Luis G; Swartz, Michael D; Yaseen, Ashraf S; Valerio-Shewmaker, Melissa A; Talebi, Yashar; Brito, Frances A; Ross, Jessica A; Kohl, Harold W; Messiah, Sarah E; Kelder, Steve H; Wu, Leqing; Zhang, Shiming; Aguillard, Kimberly A; Gonzalez, Michael O; Omega-Njemnob, Onyinye S; Lakey, David; Shuford, Jennifer A; Pont, Stephen; Boerwinkle, Eric.
Affiliation
  • DeSantis SM; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • León-Novelo LG; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Swartz MD; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Yaseen AS; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Valerio-Shewmaker MA; The University of Texas Health Science Center at Houston, School of Public Health, Brownsville Campus, Brownsville, Texas, United States of America.
  • Talebi Y; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Brito FA; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Ross JA; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Kohl HW; The University of Texas at Austin, Austin, Texas, United States of America.
  • Messiah SE; The University of Texas Health Science Center at Houston, School of Public Health, Dallas Campus, Dallas, Texas, United States of America.
  • Kelder SH; Center for Pediatric Population Health, UTHealth School of Public Health and Children's Health System of Texas, Dallas, Texas, United States of America.
  • Wu L; The University of Texas Health Science Center at Houston, School of Public Health, Austin Campus, Austin, Texas, United States of America.
  • Zhang S; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Aguillard KA; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Gonzalez MO; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Omega-Njemnob OS; The University of Texas Health Science Center at Houston, School of Public Health, Houston, Texas, United States of America.
  • Lakey D; The University of Texas Health Science Center at Houston, School of Public Health, Austin Campus, Austin, Texas, United States of America.
  • Shuford JA; The University of Texas System and the University of Texas at Tyler Health Science Center, Tyler, Texas, United States of America.
  • Pont S; Texas Department of State Health Services, Austin, Texas, United States of America.
  • Boerwinkle E; The University of Texas Health Science Center at Houston, School of Public Health, Austin Campus, Austin, Texas, United States of America.
PLoS One ; 17(9): e0273694, 2022.
Article in En | MEDLINE | ID: mdl-36084125
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos